Multiple Myeloma

GSK hails survival data with revived myeloma drug Blenrep
Pharmaphorum
Thu, 11/14/24 - 10:03 am
GSK
Blenrep
Multiple Myeloma
clinical trials
J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing
Fierce Pharma
Fri, 11/8/24 - 11:52 am
JNJ
Darzalex
Multiple Myeloma
FDA
After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data
Fierce Pharma
Mon, 09/30/24 - 09:30 am
Sanofi
JNJ
Sarclisa
Darzalex Faspro
Multiple Myeloma
FDA
2seventy Bio stops enrolling patients in blood cancer therapy study
Reuters
Wed, 09/25/24 - 11:56 am
2seventy bio
Bristol Myers Squibb
Multiple Myeloma
cell therapy
Abecma
clinical trials
Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa
Fierce Pharma
Sun, 09/22/24 - 09:44 pm
Sanofi
Sarclisa
FDA
Multiple Myeloma
Ready-to-Use Boruzu (Bortezomib) from Amneal and Shilpa Approved by FDA
Xtalks
Tue, 09/10/24 - 04:26 pm
Amneal Pharmaceuticals
Shilpa Medicare
FDA
Boruzu
Multiple Myeloma
mantle cell lymphoma
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tue, 08/20/24 - 09:59 pm
Regeneron
FDA
linvoseltamab
Multiple Myeloma
GSK plots Blenrep's plot back to market with EU filing
BioSpace
Mon, 07/22/24 - 11:33 am
GSK
Blenrep
relaunch
Multiple Myeloma
Europe
J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma
Fierce Pharma
Tue, 07/2/24 - 11:22 am
JNJ
Legend Biotech
CAR-T
Carvykti
Multiple Myeloma
clinical trials
From market withdrawal back to £3B peak sales: GSK dreams big for myeloma ADC Blenrep
Fierce Pharma
Mon, 06/17/24 - 10:32 pm
GSK
Blenrep
Multiple Myeloma
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena
Thu, 06/6/24 - 11:31 am
AbbVie
clinical trials
ABBV-383
Multiple Myeloma
Kite and Arcellx prepare to launch Phase III multiple myeloma trial
Clinical Trials Arena
Mon, 05/13/24 - 11:22 am
Kite Pharma
Gilead Sciences
Arcellx
clinical trials
anito-cel
Multiple Myeloma
As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake
Fierce Pharma
Tue, 04/9/24 - 11:36 am
FDA
Multiple Myeloma
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
FDA Rescinds Approval of Oncopeptides' Blood Cancer Treatment: Implications and What's Next
Medriva
Mon, 02/26/24 - 10:44 am
Oncopeptides
Pepaxto
FDA
Multiple Myeloma
Bi-weekly dose of Johnson & Johnson's blood cancer therapy gets US FDA approval
Reuters
Tue, 02/20/24 - 05:54 pm
JNJ
Tecvayli
FDA
Multiple Myeloma
GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma
BioSpace
Tue, 02/6/24 - 09:25 am
GSK
Blenrep
Multiple Myeloma
clinical trials
J&J, Legend to Face Adcomm for Carvykti’s Push as Earlier Line MM Treatment
BioSpace
Wed, 01/24/24 - 10:40 am
JNJ
Legend Biotech
FDA
Carvykti
Multiple Myeloma
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:45 am
ASH 2023
JNJ
Sanofi
Darzalex
Sarclisa
Multiple Myeloma
Sanofi’s Phase III multiple myeloma trial meets primary goal
Clinical Trials Arena
Fri, 12/8/23 - 11:02 am
Sanofi
cliincal trials
Sarclisa
Multiple Myeloma
monoclonal antibodies

Pages